Navigation Links
Rapid Test for Pathogens Developed By K-State Researchers Could Be Used to Detect Diseases Used By Bioterrorists
Date:8/21/2008

MANHATTAN, Kan., Aug. 21 /PRNewswire-USNewswire/ -- Dangerous disease often spreads faster than it takes to diagnose it in the lab. To remedy that, researchers at Kansas State University have developed a test to bring that time from days down to hours.

Sanjeev Narayanan, assistant professor, and Greg Peterson, research microbiologist, both in the department of diagnostic medicine and pathobiology, use a device called a DNA spotted microarray to seek out the specific genetic markers that set one pathogen apart from another and determine antibiotic resistance.

Traditionally, it takes days and multiple lab workers to screen a sample of soil, water or feces for just one pathogen. Additional time is then needed to look for resistance to antibiotics. The new test developed at K-State simultaneously looks for multiple diseases and antibiotic resistance, reducing the time it takes from sampling to diagnosis to about 24 hours.

"We needed a mass, high through-put system," Narayanan said. "The longer a serious disease goes undiagnosed, the harder it is to treat and the further it can spread."

Narayanan and Peterson have analyzed DNA of hundreds of pathogens and synthesized DNA probes for the specific genetic sequences that set each pathogen apart. So far they can detect as many as 557 genes, making it possible for them to screen for 40 different species of bacteria, 1,200 serotypes of Salmonella, five common serotypes of E. coli, and resistance to the 45 most common antibiotics used to treat human and animal illnesses caused by these pathogens.

When a sample is submitted, technicians extract and fluorescently label total DNA, and run a microarray to check whether a particular gene is present. Narayanan said the next step will be to develop a test that indicates how much of a pathogen is present, or rather how bad an infection is.

Narayanan said that he and Peterson developed the test because most human and animal infections are caused by a mixture of pathogens.

Under the current practice, it literally takes days to isolate and identify each individual pathogen and generate their antimicrobial resistance profiles. This means physicians and veterinarians often start antibiotic treatment before knowing exactly what they're up against.

"This new test will eliminate a lot of the guesswork," Narayanan said. It will tell the doctor how many different kinds of pathogens are in a sample and which antibiotics won't work, all in a shorter time frame. The test's efficiencies also translate into lower cost, he said.

Should the U.S. ever be attacked with biological weapons, Narayanan said the new test also will help in quickly identifying all of the bacterial pathogens used.

"Being able to get such quick results for so many pathogens at once will become critical in case of bioterrorism," he said. "Under that scenario, every minute counts in providing treatment or preventing disease spread."

Also, such pathogens would likely be engineered for resistance to common drug treatment and the new test would determine such resistance rapidly, Narayanan said.

The test is currently being used in research labs at K-State's College of Veterinary Medicine to detect animal and zoonotic pathogens; zoonotic pathogens can be transmitted between humans and animals. The test also is being used to monitor the flow of genetic elements in food production systems, such as feedlots. However, Narayanan hopes the test one day will be used to enhance the clinical diagnosis of animal and human infections.

The quick test was developed out of research work funded by a $100,000 K-State Targeted Excellence grant.


'/>"/>
SOURCE Kansas State University
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Michael J. Fox Foundation Funds $1.1 Million for Cutting-Edge Approaches to Parkinsons Disease Under Rapid Response Innovation Awards 2008
2. Vical Advances RapidResponse(TM) DNA Vaccine Platform Under $6 Million Grant from NIH
3. Use of Mealtime SYMLIN(R) Compared to Rapid-Acting Insulin for Diabetes Therapy Intensification in Patients With Type 2 Diabetes Using Basal Insulin
4. New CoMotion(R) Trials Software by General Dynamics Enables Rapid, Interactive Sharing of Real-time Data for Clinical Trials
5. Cardiums Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
6. Elite Team of Cyclists with Type 1 Diabetes Powers Forward in 2008 Sponsored by Rapid-Acting Insulin Apidra(R)
7. Circulation Publishes Data Showing KYNAPID(TM) (Vernakalant Hydrochloride) Injection Rapidly Converted Short-Duration Atrial Fibrillation to Sinus Rhythm
8. Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock-Out Cell Lines
9. IDX899 Demonstrates Rapid and Profound Inhibition of HIV Replication in a Phase I/II Clinical Trial in Treatment-Naive HIV-Infected Patients
10. Rapid Growth of Asia-Pacific Clinical Trials Market Focus of New CenterWatch Report
11. REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform for ... the first annual edition of its Global CSR Risk and Performance Index. ... by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data points ... ... ...
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., ... Solutions (VLMS), is pleased to announce the appointment ... member of its Board of Directors and Chairman ... VLMS enables life science companies to manage their ... use of paper in this process. Furthermore, ValGenesis ...
(Date:9/9/2017)... -- Dealmed Medical Supplies, New York City,s ... drugs, vaccines, and specialty medical products and services, announced ... acquire Vantage Medical Supplies, a major distributor of medical ... York . ... practices, will operate under the Dealmed name as of ...
Breaking Medicine Technology:
(Date:9/20/2017)... ... ... Recognising that in today’s busy world consumers are often ... in just three weeks. Setting the groundwork for a healthier lifestyle, Leany Greeny ... work and family schedules, participants can lose up to 15lbs during the program ...
(Date:9/20/2017)... ... September 20, 2017 , ... Houston, Texas, investment firm CORDA Investment Management, ... and Monday, September 11, off work and rolled up their sleeves to help with ... local homes to start the process of rebuilding. , CORDA founder Bonner C. Barnes ...
(Date:9/20/2017)... ... ... “The Financial Favor of God; Second Edition”: a personal and exquisite recipe for financial ... published author, Brooks Rathell. , “We typically hear about the favor of God. I ... of God. Not only does it exist, but it is meant for you. I ...
(Date:9/19/2017)... ... 2017 , ... Only a few physicians were selected to receive the prestigious ... Clevens, MD, FACS . The founder and medical director of Clevens Face and ... at Yale, Harvard and the University of Michigan. He has served patients throughout Central ...
(Date:9/19/2017)... ... 19, 2017 , ... Peter Chandonait, Abt Associates Principal Scientist ... (PMI) Africa Indoor Residual Spraying (AIRS) Project , has been named the Grand ... Action Award, a USAID Catalyst Award, recognizes USAID staff and implementing partners who ...
Breaking Medicine News(10 mins):